The scientist rewriting DNA, and the future of medicine

Increasing Cas9-mediated homology-directed repair efficiency through covalent tethering of DNA repair template

The CRISPR-Cas9 system is a powerful genome-editing tool in which a guide RNA targets Cas9 to a site in the genome, where the Cas9 nuclease then induces a double-stranded break (DSB). The potential of CRISPR-Cas9 to deliver precise genome editing is hindered by the low efficiency of homology-directed repair (HDR), which is required to incorporate a donor DNA template encoding desired genome edits near the DSB. We present a strategy to enhance HD…

A new form of gene therapy should be able to cure a rare lung and liver disease in the future. Experts speak of a groundbreaking progress. The first time a gene is repaired directly in the body. Veronika Simon.

The Scientist Rewriting DNA, and the Future of Medicine

The Scientist Rewriting DNA, and the Future of Medicine

The scientist rewriting DNA, and the future of medicine

A revolution is underway in gene editing -- and at its forefront is David Liu, an American molecular biologist whose pioneering work is rewriting the building blocks of life with unprecedented precision.

Redefining gene editing development and manufacturing

In this Q&A, David Butler, Chief Technology Officer at Hongene Biotech answers three key questions to provide more detail about the partnership.

Will tRNA therapy be the next big thing in genetic disease treatment?

Discover how an emerging technology called tRNA therapy could become the next big thing in genetic disease treatment. The post Will tRNA therapy be the next big thing in genetic disease treatment? appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, pr…